Provided by Tiger Fintech (Singapore) Pte. Ltd.

Virax Biolabs Group Limited

0.9606
+0.04064.41%
Post-market: 0.9600-0.0006-0.06%19:53 EDT
Volume:371.25K
Turnover:362.41K
Market Cap:4.17M
PE:-0.59
High:1.04
Open:0.9500
Low:0.9310
Close:0.9200
Loading ...

Company Profile

Company Name:
Virax Biolabs Group Limited
Exchange:
NASDAQ
Establishment Date:
2013
Employees:
19
Office Location:
BioCity Glasgow,Bo’Ness Road Newhouse,Lanarkshire,Lanarkshire,United Kingdom
Zip Code:
ML1 5UH
Fax:
- -
Introduction:
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name. It also develops T-Cell IVD test kit for COVID-19, which intend to adapt for immunological profiling against multiple viral threats under the ViraxImmune Brand, as well as a proprietary mobile application for ViraxImmune that presents an individual's immunological profiling data and provide advice on the users' immune system. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, pharmaceutical companies, research institutions, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.

Directors

Name
Position
James Foster
Director, Chief Executive Officer, Principal Accounting Officer and Chairman
Evan Norton
Independent Director
Nelson Haight
Independent Director
Nigel McCracken
Chief Operating Officer and Director
Yair Erez
Independent Director

Shareholders

Name
Position
James Foster
Director, Chief Executive Officer, Principal Accounting Officer and Chairman
Nigel McCracken
Chief Operating Officer and Director